603127 昭衍新药
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资18,970-2.86%19,52922,59825,2890
投资性房地产0--0000
固定资产567,768-2.67%583,319590,214493,153445,556
在建工程366,6297.20%342,008277,735127,36148,633
无形资产288,930-1.18%292,380299,536137,193123,631
商誉136,2430.17%136,007133,739122,431125,296
其他非流动资产1,383,551-9.69%1,531,9503,111,9881,817,166181,795
2,762,090-4.93%2,905,1924,435,8102,722,593924,911

流动资产
货币资金2,865,3140.08%2,862,9122,916,8484,154,099308,690
应收账款189,795-7.87%206,014199,437107,60688,866
存货1,694,742-9.04%1,863,0822,194,606700,587406,215
其他流动资产2,221,3131.43%2,189,959617,516852,192379,140
6,971,164-2.12%7,121,9675,928,4065,814,4841,182,911

流动负债
短期借款0--0000
应付票据0--0000
应付帐款41,090-5.15%43,323127,30953,64460,286
其他流动负债1,461,4732.63%1,424,0421,716,9531,160,598699,757
1,502,5642.40%1,467,3651,844,2621,214,242760,042
流动资产净值5,468,601-3.29%5,654,6024,084,1444,600,242422,869
资产总额减流动负债8,230,691-3.84%8,559,7958,519,9537,322,8351,347,779

非流动负债
长期借款0--03,2814,93921,375
应付债券0--0000
其他非流动负债236,963-14.99%278,754325,807173,460102,240
236,963-14.99%278,754329,087178,399123,615

总权益
    实收股本749,8890.00%749,889535,679381,246227,455
    储备项目7,243,256-3.80%7,529,4277,648,0236,754,968997,444
股东权益7,993,145-3.46%8,279,3168,183,7017,136,2141,224,899
非控股权益584-66.14%1,7257,1658,222(735)